COVID-19 cases in England fall below 500,000, ONS estimate shows

The number of people in England with COVID-19 fell below 500,000 last week for the first time since mid-October, an official estimate showed on Friday.

U.S. FDA says working to authorize Pfizer vaccine fast

(Reuters) -The U.S. Food and Drug Administration said on Friday it was working rapidly to finalize and issue an emergency use authorization for Pfizer Inc's COVID-19 vaccine.

Analysis-World watches as first-mover Britain probes adverse reactions to Pfizer vaccine

Britain hailed "V-Day" when it became the first country to roll out the Pfizer-BioNTech COVID-19 vaccine. Yet, as first mover, it has also become the first to report cases of adverse reactions, allowing other nations to watch and learn.

AstraZeneca hitches ride with Russia's Sputnik in vaccine race

AstraZeneca will start clinical trials to test a combination of its experimental COVID-19 vaccine with Russia's Sputnik V shot aimed at boosting the efficacy of the British drugmaker's vaccine, Russia's sovereign wealth fund said on Friday.

U.S. trying to secure more doses of Pfizer vaccine - FT

The U.S. government is trying to secure 100 million additional doses of Pfizer Inc's coronavirus vaccine, the Financial Times reported on Friday, citing people familiar with the order.

Any vaccine adverse effects up to national agencies to review - WHO

GENEVA (Reuters) -Any adverse effects from COVID-19 vaccines are for national authorities to review, the World Health Organization said on Friday in response to questions about Britain warning people with a history of anaphylaxis to avoid the Pfizer-BioNTech shot.

What you need to know about the coronavirus right now

(Reuters) -Here's what you need to know about the coronavirus right now:

Indiana hospital rehearses roll-out of much-anticipated COVID-19 vaccine

An Indiana hospital on Friday will conduct a rehearsal of procedures for administering Pfizer's COVID-19 vaccine, anticipating that it will be able to begin inoculating patients next week, a major step in the battle to end the pandemic.

Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight

Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.

GSK says adjuvant volume target of one billion doses under review

GlaxoSmithKline said on Friday its goal to produce 1 billion doses of adjuvants - designed to boost COVID-19 vaccine efficacy - in 2021 remained in place but was under review following a development setback with partner Sanofi. .

One million Indian doctors on strike to protest surgeries by traditional practitioners

Around a million doctors in India went on a day-long strike on Friday amid the coronavirus pandemic to protest against a new federal government rule that allows practitioners of the traditional science of Ayurveda to perform minor surgeries.

Related Videos

Adverse reactions prompt warning on UK vaccine

UK grandma receives first public Pfizer vaccine

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS